Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

NCT06677060 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

11300

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Baxdrostat and dapagliflozin
OTHER: Placebo and dapagliflozin

Sponsor

AstraZeneca